Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$101.075 1.215 | 1.22%
03/26/15 - 04:14 PM ET
Company Profile
Price and Volume
Recent Price 99.86
52 Week High 116.83
52 Week Low 63.50
Avg. Daily Vol. (Mil) 13.68
Beta (3 year) 0.83
Share Related Items
Mkt Cap (Mil) 148,731.65
Shares Out (Mil) 1,489.40
Float (Mil) 1,529.66
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.60
Current Ratio 3.10
LT Debt/ Equity 0.77
Total Debt / Equity 0.80
Valuation Ratios
Price Earnings 13.60
Price/Sales 5.98
Price/Book 9.64
Price/Cash Flow 11.30
Per Share Data
Earnings 7.35
Sales 16.71
Book Value 10.36
Cash Flow 8.80
Business Summary
Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.
General Information
333 Lakeside Drive
Foster City, CA 94404
www.gilead.com
Industry : Drugs
Sector: Health Care
Employees: 7000
CEO: Dr. John C. Martin,M.D.
Short Interest
Current Month (Mil) 55.99
Previous Month (Mil) 56.21
Short Interest Ratio (Days) 6.30
Management Effectiveness
Return on Equity 78.20
Return on Assets 34.80
Return on Investments 44.10
Profitability
Gross Margin 89.00
EBIT Margin 61.30
Profit Margin 48.40

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter